<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113576/" ref="ordinalpos=788&amp;ncbi_uid=6484422&amp;link_uid=PMC4113576" image-link="/pmc/articles/PMC4113576/figure/f3-etm-08-03-1005/" class="imagepopup">Figure 3.  From: Inhibition of Aurora-B suppresses HepG2 cell invasion and migration via the PI3K/Akt/NF-?B <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> in vitro. </a></div><br /><div class="p4l_captionBody">Inhibiting Aurora-B expression decreases the activity of the PI3K/Akt/NF-κB signaling pathway. With the downregulation of Aurora-B, the p-Akt, Akt, MMP-2, MMP-9 and NF-κB protein expression levels decreased significantly in the cells transfected with MiR-Aurora-B when compared with the cells transfected with MiR-Neg. NF-κB, nuclear factor-κB, MMP, matrix metalloproteinase; PI3K, phosphoinositide 3-kinase,</div></div>